EISSN 2148-5607

TJG is categorized as Q3 in JIF. TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.6

Turkish Journal of Gastroenterology

36 428 2025

HIGHLY CITED ARTICLES

Correlation Between Kidney Function and Intestinal Biological Characteristics of Adenine and Folium SennaeInduced Diarrhea Model in Mice

Xiaoya Li, Jiayuan Zhu, Yi Wu, Zhoujin Tan

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives

Bernel et al.

Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?

Kantarcıoğlu et al.

Epigenetics of Inflammatory Bowel Diseases

Törüner and Ünal

Vonoprazan on the Eradication of Helicobacter pylori Infection

Huang and Lin

Acute Pancreatitis Review

Huang and Badurdeen

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Letter to the Editor

What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?

Gökhan KABAÇAM ¹ , Murat TÖRÜNER ²

Author Affiliation(s)

1.

Department of Gastroenterology, Ankara Lokman Hekim Hospital, Ankara

2.

Department of Gastroenterology, Ankara University School of Medicine, Ankara

Turk J Gastroenterol 2010; 21: 107-112

DOI: 10.4318/tjg.2010.0066

Keywords : Crohn hastalığı, luminal Crohn hastalığı, anti TNF tedavi

Read: 2123 Downloads: 1739 Published: 25 July 2019

Volume 21, Issue 1, March 2010

Previous Article

Files